PDB112 - TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
- Resource Type
- Abstract
- Source
- In
Value in Health October 2018 21 Supplement 3:S137-S137 - Subject
- Language
- ISSN
- 1098-3015